Mizuho Securities USA’s Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 TRCA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-56,961
Closed -$570 251
2023
Q3
$570 Buy
+56,961
New +$3.05K ﹤0.01% 222

Mizuho Securities USA's TRCA.WS Position: Q4 2023 in Review

Mizuho Securities USA sold out of Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (TRCA.WS) in Q4 2023, closing a stake of 56,961 shares — an estimated $570 sold.

Mizuho Securities USA first reported a position in TRCA.WS in Q3 2023 and held it in 1 quarter. The position peaked at $570 in Q3 2023. 0 funds tracked by Wall St. Rank hold TRCA.WS as of Q4 2023.

  • Mizuho Securities USA reported no remaining Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
  • Mizuho Securities USA sold 56,961 Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2023, an estimated $570.
  • Mizuho Securities USA first reported a position in Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2023 and held it in 1 quarter.
  • Mizuho Securities USA's Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $570 in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2023.

Based on Mizuho Securities USA's 13F filing for Q4 2023, filed 8 Feb 2024.